Ocular Therapeutix, Inc SEC filings OCUL

Ocular Therapeutix, Inc has 865 filings in SEC EDGAR's recent list, going back to Mar 6, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.

Ocular Therapeutix, Inc SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 5, 2026 —
8-K Current report
Officer or director change
Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 13, 2026 Oct 8, 2026
144 Notice of proposed sale Oct 8, 2026 —
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
144 Notice of proposed sale Oct 2, 2026 —
144 Notice of proposed sale Oct 2, 2026 —
4 Insider transaction Sep 2, 2026 Aug 31, 2026
144 Notice of proposed sale Aug 31, 2026 —
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
144 Notice of proposed sale Aug 24, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
S-8 Employee stock plan registration Aug 3, 2026 —
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 5, 2026 Jun 3, 2026
144 Notice of proposed sale Jun 3, 2026 —
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 28, 2026 May 26, 2026
4 Insider transaction May 28, 2026 May 26, 2026
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 26, 2026 —
144 Notice of proposed sale May 26, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 11, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
4 Insider transaction Apr 13, 2026 Apr 9, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Regulation FD disclosure
Feb 27, 2026 Feb 27, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 23, 2026 —
144 Notice of proposed sale Feb 20, 2026 —
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 10, 2026 —
S-8 Employee stock plan registration Feb 5, 2026 —
10-K Annual report Feb 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 5, 2026 Feb 5, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Jan 26, 2026 Jan 21, 2026
3 Initial insider ownership Jan 26, 2026 Jan 21, 2026
8-K Current report
Officer or director change
Jan 23, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
3 Initial insider ownership Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
8-K Current report
Other events
Dec 18, 2025 Dec 18, 2025
SCHEDULE 13G Ownership over 5% (passive) Dec 8, 2025 —
8-K Current report
Other events
Dec 5, 2025 Dec 5, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
4 Insider transaction Nov 26, 2025 Nov 24, 2025
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
144 Notice of proposed sale Nov 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 10, 2025 Oct 8, 2025
144 Notice of proposed sale Oct 8, 2025 —
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
424B5 Prospectus supplement Sep 30, 2025 —
8-K Current report
Material agreement, Other events
Sep 30, 2025 Sep 30, 2025
8-K Current report
Other events
Sep 30, 2025 Sep 30, 2025
S-3ASR Automatic shelf registration Sep 30, 2025 —
4 Insider transaction Sep 11, 2025 Sep 9, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
4 Insider transaction Aug 27, 2025 Aug 25, 2025
4 Insider transaction Aug 27, 2025 Aug 25, 2025
4 Insider transaction Aug 27, 2025 Aug 25, 2025
4 Insider transaction Aug 27, 2025 Aug 25, 2025
144 Notice of proposed sale Aug 25, 2025 —
144 Notice of proposed sale Aug 25, 2025 —
144 Notice of proposed sale Aug 25, 2025 —
144 Notice of proposed sale Aug 25, 2025 —
4 Insider transaction Aug 14, 2025 Aug 12, 2025
4 Insider transaction Aug 13, 2025 Apr 28, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 8, 2025 —
3 Initial insider ownership Jun 23, 2025 Jun 11, 2025
3 Initial insider ownership Jun 23, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
S-8 Employee stock plan registration Jun 11, 2025 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Jun 11, 2025 Jun 11, 2025
4 Insider transaction Jun 3, 2025 Jun 2, 2025
144 Notice of proposed sale Jun 2, 2025 —
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
4 Insider transaction May 27, 2025 May 23, 2025
144 Notice of proposed sale May 23, 2025 —
144 Notice of proposed sale May 23, 2025 —
144 Notice of proposed sale May 23, 2025 —
144 Notice of proposed sale May 23, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 12, 2025 May 8, 2025
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 5, 2025 May 5, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 11, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 11, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
144 Notice of proposed sale Feb 24, 2025 —
8-K Current report
Officer or director change
Feb 14, 2025 Feb 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 13, 2025 Feb 11, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
144 Notice of proposed sale Feb 4, 2025 —
144 Notice of proposed sale Jan 31, 2025 —
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 27, 2024 Nov 25, 2024
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
S-8 Employee stock plan registration Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OCUL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedford, MA
SEC filer status
Large accelerated filer
SEC CIK
1393434
Former names
I-THERAPEUTIX INC (until Jul 2, 2009)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.